Showing 1 - 7 results of 7 for search 'J. Kanter', query time: 0.02s
Refine Results
-
1
-
2
P1472: INTERIM RESULTS OF SAFETY, TOLERABILITY, PHARMACOKINETICS, AND PHARMACODYNAMICS FROM AN ONGOING OPEN-LABEL STUDY INVESTIGATING FTX-6058 IN ADULTS LIVING WITH SICKLE CELL DIS... by P. Bruno, J. Kanter, J. Ziegler, B. Stuart, J. Ahn, J. Dunn, G. Allen, C. Morabito
Published 2022-06-01
Article -
3
S122: SAFETY AND EFFICACY OF CRIZANLIZUMAB IN ADOLESCENTS WITH SICKLE CELL DISEASE (SCD): INITIAL DATA FROM THE PHASE II, MULTICENTER, OPEN-LABEL SOLACE-KIDS TRIAL by M Heeney, D Rees, M de Montalembert, I Odame, C Brown, Y Wali, T Nguyen, D Lam, N Pfender, J Kanter
Published 2022-01-01
Article -
4
S108: A SYSTEMATIC POST-MARKETING (PM) REVIEW OF RARE INFUSION-RELATED REACTIONS (IRRS) PRESENTING AS PAIN EVENTS DURING OR AFTER CRIZANLIZUMAB INFUSION IN PATIENTS WITH SICKLE CEL... by J Kanter, A Shah, V Joshi, H Mehta, M Levine, U Arunagiri, J Paulose, B Donohue, A Scalera, D Manwani
Published 2022-01-01
Article -
5
S120: RANDOMIZED CONTROLLED TRIAL OF THE EFFICACY AND SAFETY OF DEFERIPRONE: SUBGROUP ANALYSIS OF PEDIATRIC PATIENTS IN IRON-OVERLOADED PATIENTS WITH SICKLE CELL DISEASE AND OTHER... by B Inusa, M Hamdy, A El-Beshlawy, F Ebeid, J Kwiatkowski, J Kanter, S Williams, D Lee, N Temin, C Fradette, F Tricta, M Elalfy
Published 2022-01-01
Article -
6
5613436 EXPERT CONSENSUS ON THE MANAGEMENT OF INFUSION-RELATED REACTIONS (IRRS) PRESENTING WITH PAIN IN PATIENTS RECEIVING CRIZANLIZUMAB by J. Kanter, K. Ataga, N. Bhasin, S. Guarino, A. Kutlar, S. Lanzkron, D. Manwani, P. McGann, S. Stowell, V. Tubman, I. Yermilov, C. Campos, M.S. Broder
Published 2023-04-01
Article -
7
S115: LONG-TERM EFFICACY AND SAFETY OF DEFERIPRONE FOR PATIENTS WITH SICKLE CELL DISEASE OR OTHER ANEMIAS by B Inusa, M Hamdy, A El-Beshlawy, F Ebeid, J Kwiatkowski, J Kanter, S Williams, D Lee, N Temin, C Fradette, F Tricta, M Elalfy
Published 2022-01-01
Article